Biodesix, Inc. Common Stock

BDSX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
BDSX Income Statement
BDSX Balance Sheet
BDSX Cash Flow
Congress Trading

Recent trades of BDSX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
BDSX Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
BDSX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
BDSX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by BDSX's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $30,000 Oct 21, 2024 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jul 18, 2024 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 22, 2024 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jan 22, 2024 Issue: Health Issues Medicare/Medicaid
  • $30,000 Oct 20, 2023 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jul 20, 2023 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jan 20, 2023 Issue: Health Issues Medicare/Medicaid
  • $30,000 Oct 20, 2022 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jul 20, 2022 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jan 19, 2022 Issue: Medicare/Medicaid Health Issues
  • $30,000 Oct 15, 2021 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jul 20, 2021 Issue: Medicare/Medicaid Health Issues
  • $30,000 Apr 13, 2021 Issue: Health Issues Medicare/Medicaid
  • $30,000 Jan 20, 2021 Issue: Medicare/Medicaid Health Issues
  • $30,000 Jul 14, 2020 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $60,000 Jun 27, 2020 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Copyright/Patent/Trademark
  • $30,000 Apr 17, 2020 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $30,000 Jan 21, 2020 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $59,235 Oct 18, 2019 Issue: Medicare/Medicaid Copyright/Patent/Trademark Medical/Disease Research/Clinical Labs
  • $58,000 Jul 18, 2019 Issue: Copyright/Patent/Trademark Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Apr 22, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Jan 22, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Oct 19, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $30,000 Jul 19, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $30,000 Apr 20, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $30,000 Jan 22, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $30,000 Oct 20, 2017 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $30,000 Apr 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $30,000 Jan 24, 2017 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Oct 18, 2016 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Jul 20, 2016 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $30,000 Apr 20, 2016 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $5,000 Mar 10, 2016 Issue: Health Issues
  • $30,000 Jan 20, 2016 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Apparatus and method for identification of primary immune resistance in cancer patients Sep. 17, 2024
  • Patent Title: Compositions, methods and kits for diagnosis of lung cancer Feb. 27, 2024
  • Patent Title: Method for predicting risk of unfavorable outcomes, e.g., in covid-19 hospitalization, from clinical characteristics and basic laboratory findings Feb. 06, 2024
  • Patent Title: Predictive test for melanoma patient benefit from interleukin-2 (il2) therapy Jul. 25, 2023
  • Patent Title: Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy Apr. 04, 2023
  • Patent Title: Predictive test for prognosis of myelodysplastic syndrome patients using mass spectrometry of blood-based sample Feb. 28, 2023
  • Patent Title: Antibodies targeting pulmonary nodule specific biomarkers and uses thereof Jan. 03, 2023
  • Patent Title: Method for predicting risk of unfavorable outcomes, e.g., in covid-19 hospitalization, from clinical characteristics and basic laboratory findings Oct. 18, 2022
  • Patent Title: Srm methods in alzheimer's disease and neurological disease assays Oct. 11, 2022
  • Patent Title: Compositions, methods and kits for diagnosis of lung cancer Dec. 07, 2021
  • Patent Title: Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups Oct. 19, 2021
  • Patent Title: Predictive test for patient benefit from antibody drug blocking ligand activation of the t-cell programmed cell death 1 (pd-1) checkpoint protein and classifier development methods Mar. 16, 2021
  • Patent Title: Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood Dec. 22, 2020
  • Patent Title: Compositions, methods and kits for diagnosis of lung cancer Oct. 13, 2020
  • Patent Title: Bagged filtering method for selection and deselection of features for classification Jul. 14, 2020
  • Patent Title: Selected reaction monitoring assays Jan. 14, 2020
  • Patent Title: Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample Nov. 26, 2019
  • Patent Title: Blood sample separation devices and methods Sep. 24, 2019
  • Patent Title: Compositions, methods and kits for diagnosis of lung cancer Jul. 02, 2019
  • Patent Title: Early detection of hepatocellular carcinoma in high risk populations using maldi-tof mass spectrometry Feb. 26, 2019
  • Patent Title: Early detection of hepatocellular carcinoma in high risk populations using maldi-tof mass spectrometry Jul. 31, 2018
  • Patent Title: Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the t-cell programmed cell death 1 (pd-1) checkpoint protein and classifier development methods Jun. 26, 2018
  • Patent Title: Method and system for determining whether a drug will be effective on a patient with a disease Nov. 21, 2017
  • Patent Title: Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample Oct. 03, 2017
  • Patent Title: Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies May. 16, 2017
  • Patent Title: Deep maldi tof mass spectrometry of complex biological samples, e.g., serum, and uses thereof Mar. 28, 2017
  • Patent Title: Method of predicting development and severity of graft-versus-host disease Feb. 07, 2017
  • Patent Title: Classification generation method using combination of mini-classifiers with regularization and uses thereof Oct. 25, 2016
  • Patent Title: Deep-maldi tof mass spectrometry of complex biological samples, e.g., serum, and uses thereof Mar. 08, 2016
  • Patent Title: Method for predicting breast cancer patient response to combination therapy Feb. 09, 2016
  • Patent Title: Treatment selection for lung cancer patients using mass spectrum of blood-based sample Dec. 15, 2015
  • Patent Title: Method and system for determining whether a drug will be effective on a patient with a disease Oct. 06, 2015
  • Patent Title: Method for predicting breast cancer patient response to endocrine therapy Dec. 16, 2014
  • Patent Title: Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents May. 06, 2014
  • Patent Title: Monitoring treatment of head and neck cancer patients with drugs targeting egfr pathway using mass spectrometry of patient samples Nov. 19, 2013
  • Patent Title: Monitoring treatment of colorectal cancer patients with drugs targeting egfr pathway using mass spectrometry of patient samples Nov. 19, 2013
  • Patent Title: Method and system for validation of mass spectrometer machine performance Jun. 18, 2013
  • Patent Title: Monitoring treatment of colorectal cancer patients with drugs targeting egfr pathway using mass spectrometry of patient samples Feb. 21, 2012
  • Patent Title: Monitoring treatment of head and neck cancer patients with drugs egfr pathway using mass spectrometry of patient samples Feb. 21, 2012
  • Patent Title: Method and system for determining whether a drug will be effective on a patient with a disease Jan. 17, 2012
  • Patent Title: Method for reliable classification of samples in clinical diagnostics using an improved method of classification Sep. 20, 2011
  • Patent Title: Monitoring treatment of cancer patients with drugs targeting egfr pathway using mass spectrometry of patient samples Mar. 15, 2011
  • Patent Title: Method and system for determining whether a drug will be effective on a patient with a disease Feb. 01, 2011
  • Patent Title: Selection of head and neck cancer patients for treatment with drugs targeting egfr pathway Jan. 11, 2011
  • Patent Title: Selection of colorectal cancer patients for treatment with drugs targeting egfr pathway Dec. 28, 2010
  • Patent Title: Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting egfr pathway Dec. 28, 2010
  • Patent Title: Method and system for determining whether a drug will be effective on a patient with a disease Jun. 15, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of BDSX in WallStreetBets Daily Discussion

BDSX News

Recent insights relating to BDSX

CNBC Recommendations

Recent picks made for BDSX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BDSX

BDSX Top Shareholders
Shareholder
Shares Held
BDSX Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

BDSX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view BDSX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top